(EDEN) Edenred - Ratings and Ratios
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0010908533
Meal Vouchers, Fuel Cards, Gift Vouchers, Mobility Platform, Expense Management
| Risk via 10d forecast | |
|---|---|
| Volatility | 55.1% |
| Value at Risk 5%th | 81.2% |
| Relative Tail Risk | -10.44% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.78 |
| Alpha | -34.74 |
| Character TTM | |
|---|---|
| Hurst Exponent | |
| Beta | 0.143 |
| Beta Downside | 0.255 |
| Drawdowns 3y | |
|---|---|
| Max DD | 66.49% |
| Mean DD | 29.43% |
| Median DD | 28.27% |
Description: EDEN Edenred November 05, 2025
Edenred SE operates a global digital platform that delivers employee benefit and corporate payment solutions to companies, workers, and merchants. Its flagship offerings include Ticket Restaurant (lunch vouchers), Ticket Alimentación (grocery payments), and Ticket CESU (human-services vouchers), alongside specialized products such as EcoCheque for green purchases and cultural vouchers (Kadéos Culture, Ticket Cultura).
The firm’s mobility portfolio comprises Ticket Car (fuel and travel expense cards), Ticket Fleet Pro (truck-fleet management), Spirii (electric-vehicle charging), and cloud-based services like Cintelink for service-station operators. Additional services cover corporate incentives, rewards, and public-sector social programmes.
Founded in 1962 and headquartered in Issy-les-Moulineaux, France, Edenred is listed under ticker EDEN (common stock) and classified in GICS as Diversified Support Services.
Recent performance metrics (FY 2023) show revenue of approximately €5.5 billion, a year-over-year growth of 5 % driven largely by digital adoption of benefit cards, and an operating margin of 14 %. The business benefits from macro-level trends such as rising corporate spending on employee well-being, accelerated digitisation of payment ecosystems, and increasing ESG-related demand for green-voucher programs.
For a deeper quantitative breakdown of Edenred’s valuation multiples and scenario analysis, you may find the ValueRay platform useful.
EDEN Stock Overview
| Market Cap in USD | 6,938m |
| Sub-Industry | Diversified Support Services |
| IPO / Inception | |
| Return 12m vs S&P 500 | -38.3% |
| Analyst Rating | - |
EDEN Dividends
| Dividend Yield | 6.25% |
| Yield on Cost 5y | 2.96% |
| Yield CAGR 5y | 11.96% |
| Payout Consistency | 92.7% |
| Payout Ratio | 58.5% |
EDEN Growth Ratios
| CAGR 3y | -26.39% |
| CAGR/Max DD Calmar Ratio | -0.40 |
| CAGR/Mean DD Pain Ratio | -0.90 |
| Current Volume | 1165.6k |
| Average Volume | 1006.4k |
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (807.0m TTM) > 0 and > 6% of Revenue (6% = 310.7m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA 9.50pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -27.66% (prev -12.59%; Δ -15.06pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 1.51b > Net Income 807.0m (YES >=105%, WARN >=100%) |
| Net Debt (3.76b) to EBITDA (2.06b) ratio: 1.82 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.86 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (247.6m) change vs 12m ago -6.36% (target <= -2.0% for YES) |
| Gross Margin 47.01% (prev 54.88%; Δ -7.87pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 40.00% (prev 20.22%; Δ 19.78pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.73 (EBITDA TTM 2.06b / Interest Expense TTM 282.0m) >= 6 (WARN >= 3) |
Altman Z'' -0.45
| (A) -0.11 = (Total Current Assets 8.55b - Total Current Liabilities 9.98b) / Total Assets 13.32b |
| (B) -0.14 = Retained Earnings (Balance) -1.86b / Total Assets 13.32b |
| (C) 0.12 = EBIT TTM 1.62b / Avg Total Assets 12.95b |
| (D) -0.12 = Book Value of Equity -1.79b / Total Liabilities 14.37b |
| Total Rating: -0.45 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 77.17
| 1. Piotroski 7.0pt = 2.0 |
| 2. FCF Yield 13.89% = 5.0 |
| 3. FCF Margin 28.20% = 7.05 |
| 4. Debt/Equity -4.60 = -2.50 |
| 5. Debt/Ebitda 1.82 = 0.35 |
| 6. ROIC - WACC (= 24.82)% = 12.50 |
| 7. RoE -87.55% = -2.50 |
| 8. Rev. Trend 67.78% = 5.08 |
| 9. EPS Trend 3.80% = 0.19 |
What is the price of EDEN shares?
As of November 16, 2025, the stock is trading at EUR 19.37 with a total of 1,165,641 shares traded.
Over the past week, the price has changed by -7.34%, over one month by -6.40%, over three months by -25.63% and over the past year by -29.30%.
Over the past week, the price has changed by -7.34%, over one month by -6.40%, over three months by -25.63% and over the past year by -29.30%.
Is Edenred a good stock to buy?
Partly, yes. Based on ValueRay´s Fundamental Analyses, Edenred (PA:EDEN) is currently (November 2025)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 77.17 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EDEN is around 16.99 EUR . This means that EDEN is currently overvalued and has a potential downside of -12.29%.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EDEN is around 16.99 EUR . This means that EDEN is currently overvalued and has a potential downside of -12.29%.
Is EDEN a buy, sell or hold?
Edenred has no consensus analysts rating.
What are the forecasts/targets for the EDEN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 34.9 | 79.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 18.2 | -6.1% |
EDEN Fundamental Data Overview January 01, 1970
Market Cap USD = 6.94b (5.99b EUR * 1.159 EUR.USD)
Market Cap EUR = 5.99b (5.99b EUR * 1.0 EUR.EUR)
P/E Trailing = 10.1884
P/E Forward = 7.7519
P/S = 2.2363
P/EG = 0.7829
Beta = 0.388
Revenue TTM = 5.18b EUR
EBIT TTM = 1.62b EUR
EBITDA TTM = 2.06b EUR
Long Term Debt = 3.88b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.27b EUR (from shortTermDebt, last quarter)
Debt = 5.35b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.76b EUR (from netDebt column, last quarter)
Enterprise Value = 10.51b EUR (5.99b + Debt 5.35b - CCE 827.0m)
Interest Coverage Ratio = 5.73 (Ebit TTM 1.62b / Interest Expense TTM 282.0m)
FCF Yield = 13.89% (FCF TTM 1.46b / Enterprise Value 10.51b)
FCF Margin = 28.20% (FCF TTM 1.46b / Revenue TTM 5.18b)
Net Margin = 15.59% (Net Income TTM 807.0m / Revenue TTM 5.18b)
Gross Margin = 47.01% ((Revenue TTM 5.18b - Cost of Revenue TTM 2.74b) / Revenue TTM)
Gross Margin QoQ = 42.87% (prev 52.17%)
Tobins Q-Ratio = 0.79 (Enterprise Value 10.51b / Total Assets 13.32b)
Interest Expense / Debt = 1.94% (Interest Expense 104.0m / Debt 5.35b)
Taxrate = 35.53% (140.0m / 394.0m)
NOPAT = 1.04b (EBIT 1.62b * (1 - 35.53%))
Current Ratio = 0.86 (Total Current Assets 8.55b / Total Current Liabilities 9.98b)
Debt / Equity = -4.60 (negative equity) (Debt 5.35b / totalStockholderEquity, last quarter -1.16b)
Debt / EBITDA = 1.82 (Net Debt 3.76b / EBITDA 2.06b)
Debt / FCF = 2.58 (Net Debt 3.76b / FCF TTM 1.46b)
Total Stockholder Equity = -921.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.06% (Net Income 807.0m / Total Assets 13.32b)
RoE = -87.55% (negative equity) (Net Income TTM 807.0m / Total Stockholder Equity -921.8m)
RoCE = 54.57% (EBIT 1.62b / Capital Employed (Equity -921.8m + L.T.Debt 3.88b))
RoIC = 28.87% (NOPAT 1.04b / Invested Capital 3.61b)
WACC = 4.05% (E(5.99b)/V(11.33b) * Re(6.54%) + D(5.35b)/V(11.33b) * Rd(1.94%) * (1-Tc(0.36)))
Discount Rate = 6.54% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -3.30%
[DCF Debug] Terminal Value 76.08% ; FCFE base≈949.0m ; Y1≈825.6m ; Y5≈663.0m
Fair Price DCF = 50.84 (DCF Value 12.07b / Shares Outstanding 237.4m; 5y FCF grow -15.89% → 3.0% )
EPS Correlation: 3.80 | EPS CAGR: -70.94% | SUE: 0.0 | # QB: 0
Revenue Correlation: 67.78 | Revenue CAGR: 69.82% | SUE: N/A | # QB: 0
Market Cap EUR = 5.99b (5.99b EUR * 1.0 EUR.EUR)
P/E Trailing = 10.1884
P/E Forward = 7.7519
P/S = 2.2363
P/EG = 0.7829
Beta = 0.388
Revenue TTM = 5.18b EUR
EBIT TTM = 1.62b EUR
EBITDA TTM = 2.06b EUR
Long Term Debt = 3.88b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.27b EUR (from shortTermDebt, last quarter)
Debt = 5.35b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.76b EUR (from netDebt column, last quarter)
Enterprise Value = 10.51b EUR (5.99b + Debt 5.35b - CCE 827.0m)
Interest Coverage Ratio = 5.73 (Ebit TTM 1.62b / Interest Expense TTM 282.0m)
FCF Yield = 13.89% (FCF TTM 1.46b / Enterprise Value 10.51b)
FCF Margin = 28.20% (FCF TTM 1.46b / Revenue TTM 5.18b)
Net Margin = 15.59% (Net Income TTM 807.0m / Revenue TTM 5.18b)
Gross Margin = 47.01% ((Revenue TTM 5.18b - Cost of Revenue TTM 2.74b) / Revenue TTM)
Gross Margin QoQ = 42.87% (prev 52.17%)
Tobins Q-Ratio = 0.79 (Enterprise Value 10.51b / Total Assets 13.32b)
Interest Expense / Debt = 1.94% (Interest Expense 104.0m / Debt 5.35b)
Taxrate = 35.53% (140.0m / 394.0m)
NOPAT = 1.04b (EBIT 1.62b * (1 - 35.53%))
Current Ratio = 0.86 (Total Current Assets 8.55b / Total Current Liabilities 9.98b)
Debt / Equity = -4.60 (negative equity) (Debt 5.35b / totalStockholderEquity, last quarter -1.16b)
Debt / EBITDA = 1.82 (Net Debt 3.76b / EBITDA 2.06b)
Debt / FCF = 2.58 (Net Debt 3.76b / FCF TTM 1.46b)
Total Stockholder Equity = -921.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.06% (Net Income 807.0m / Total Assets 13.32b)
RoE = -87.55% (negative equity) (Net Income TTM 807.0m / Total Stockholder Equity -921.8m)
RoCE = 54.57% (EBIT 1.62b / Capital Employed (Equity -921.8m + L.T.Debt 3.88b))
RoIC = 28.87% (NOPAT 1.04b / Invested Capital 3.61b)
WACC = 4.05% (E(5.99b)/V(11.33b) * Re(6.54%) + D(5.35b)/V(11.33b) * Rd(1.94%) * (1-Tc(0.36)))
Discount Rate = 6.54% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -3.30%
[DCF Debug] Terminal Value 76.08% ; FCFE base≈949.0m ; Y1≈825.6m ; Y5≈663.0m
Fair Price DCF = 50.84 (DCF Value 12.07b / Shares Outstanding 237.4m; 5y FCF grow -15.89% → 3.0% )
EPS Correlation: 3.80 | EPS CAGR: -70.94% | SUE: 0.0 | # QB: 0
Revenue Correlation: 67.78 | Revenue CAGR: 69.82% | SUE: N/A | # QB: 0